Related Experiment Videos
Venlafaxine and treatment-resistant depression
M E Thase1, E S Friedman, R H Howland
1University of Pittsburgh School of Medicine, Department of Psychiatry, Pennsylvania, USA. thaseme@msx.upmc.edu
Depression and Anxiety
|December 1, 2000
Summary
Treatment-resistant depression (TRD) can be effectively managed with higher doses of venlafaxine, offering a well-tolerated alternative. This approach is recommended before considering older antidepressants like TCAs or MAOIs for TRD.
Area of Science:
- Psychiatry
- Clinical Pharmacology
Background:
- Treatment-resistant depression (TRD) presents a significant clinical challenge.
- Standard antidepressant therapies are ineffective for a subset of patients.
Purpose of the Study:
- To review the definition and research methodologies for TRD.
- To evaluate venlafaxine as a treatment option for TRD.
Main Methods:
- Review of recent studies on venlafaxine for TRD.
- Analysis of methodological issues in TRD treatment research.
Main Results:
- Higher doses of venlafaxine are well-tolerated and effective for TRD.
- Venlafaxine is a viable alternative to TCAs and MAOIs.
Conclusions:
- Venlafaxine should be considered before TCAs or MAOIs for TRD.
- Further research is needed on switching strategies from SSRIs to venlafaxine or other agents.